U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Bizarre Patents

Patent No. 6681419

Forehead support apparatusĀ 

A forehead support apparatus for resting a standing users forehead against a wall above a bathroom commode or urinal or beneath a showerhead.

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 546/284.1 - Polycyclo ring system having the additional hetero ring as one of the cyclos


Subclass of Class 546 - Organic compounds -- part of the class 532-570 series
Definition: Compounds wherein the additional hetero ring is one of the
No. of applications: 65
Last issue date: 04/05/2012


1    
Application No.Application TitleIssue Date
20120083488TETRACYCLIC COMPOUND
A compound represented by the general Formula (I) below, or a salt or solvate thereof, which is useful as an ALK inhibitor, and is useful for prophylaxis or treatment of a disease accompanied by abnormality in ALK, for example, cancer, cancer metastasis, depression or c...
04/05/2012
20120071487PIPERAZINE, PIPERIDINE AND TETRAHYDROPYRIDINE DERIVATIVES AND THEIR PHARMACEUTICAL USE
Novel piperazine, piperidine and tetrahydropyridine derivatives comprising a dibenzofurane moiety are provided herein, as well as pharmaceutical compositions comprising same and therapeutic uses thereof....
03/22/2012
20120053132COMPOSITIONS AND METHODS FOR INHIBITING CYTOCHROME P450
Methods of inhibiting cytochrome P450 enzymes are provided that can be used for improving the treatment of diseases by preventing degradation of drugs or other molecules by cytochrome P450. Pharmaceutical compositions are provided that can act as boosters to improve the...
03/01/2012
20120053173HETEROCYCLIC COMPOUND
Provision of a prophylactic or therapeutic agent for diabetes, which has superior efficacy.

A compound represented by the formula:

wherein each symbol is as described in the spec...

03/01/2012
20120010247BICYCLIC COMPOUND
The present invention provides a compound having an ACC inhibitory action, which is useful as an agent for the prophylaxis or treatment of obesity, diabetes, hypertension, hyperlipidemia, cardiac failure, diabetic complications, metabolic syndrome, sarcopenia, cancer an...
01/12/2012
20110275625Heteroaryl Diamide Compounds Useful as MMP-13 Inhibitors
Disclosed are compounds and compositions of the formula (I) as described herein which are inhibitors of MMP-13. Also disclosed are methods of using and making compounds of the formula (I).

...

11/10/2011
20110272681LIGHT-EMITTING ELEMENT MATERIAL AND LIGHT-EMITTING ELEMENT
A light-emitting element has high luminous efficiency and excellent durability. The light-emitting element includes at least a light-emitting layer between a positive electrode and a negative electrode, and emits light by electrical energy. The light-emitting element is...
11/10/2011
20110230350ARYL-AND HETARYLSULFONAMIDES AS ACTIVE INGREDIENTS AGAINST ABIOTIC PLANT STRESS
Use of substituted sulfonamides of the formula (I) or salts thereof

for enhancing stress tolerance in plants to abiotic stress, especially for enhancing plant growth and/or for increasing plant yield....

09/22/2011
20110212940S1P Receptor Modulating Compounds and Use Thereof
The present invention relates to compounds of the general formula (I) that have activity as S1P receptor modulating agents and the use of such compounds to treat diseases associated with inappropriate S1P receptor activity. The compounds may be used as immunomodulators,...
09/01/2011
20110201815FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF FOR MEDICAL PURPOSES
The present invention provides compounds useful as agents for the prevention or treatment of a disease associated with abnormal plasma uric acid level and the like. The present invention relates to fused heterocyclic derivatives represented by the following formula (I) ...
08/18/2011
20110118248Heteroaryl sulfonamides and CCR2/CCR9
Compounds are provided that act as potent antagonists of the CCR2 receptor. Animal testing demonstrates that these compounds are useful for treating inflammation, a hallmark disease for CCR2. The compounds are generally aryl sulfonamide derivatives and are useful in pha...
05/19/2011
20110112142NOVEL ESTROGEN RECEPTOR LIGANDS
The invention provides a pharmaceutical composition comprising a compound of formula (I) or a pharmaceutically acceptable ester, amide, solvate or salt thereof, including a salt of such an ester or amide, and a solvate of such an ester, amide or salt: wherein R3
05/12/2011
20110098236DIAMIDE INHIBITORS OF CYTOCHROME P450
Methods of inhibiting cytochrome P450 enzymes are provided that can be used for improving the treatment of diseases by preventing degradation of drugs or other molecules by cytochrome P450. Pharmaceutical compositions are provided that can act as boosters to improve the...
04/28/2011
20110098237METHODS FOR INHIBITING DRUG DEGRADATION
Methods of inhibiting cytochrome P450 enzymes are provided that can be used for improving the treatment of diseases by preventing degradation of drugs or other molecules by cytochrome P450. Pharmaceutical compositions are provided that can act as boosters to improve the...
04/28/2011
20110086877Small Molecule Inhibitors of Botulinum Neurotoxins
Disclosed herein are methods of inhibiting the activity of Botulinum neurotoxin A metalloprotease with the compounds disclosed herein. Also disclosed are methods of treating, inhibiting or preventing intoxication caused by bacteria of at least one bacterial strain in a ...
04/14/2011
20110065631PROCESS FOR PREPARATION OF HIV PROTEASE INHIBITORS
A process for the synthesis of bisfuran intermediates of formula (0) useful for preparing antiviral HIV protease inhibitor compounds is hereby disclosed. Furthermore disclosed is a HIV protease inhibitor of formula (IV) as well as various intermediates thereof.

03/17/2011
20110061723DYE SENSITISED SOLAR CELL
The present invention pertains to an electrode layer comprising a porous film made of oxide semiconductor fine particles sensitized with certain methin dyes. Moreover the present invention pertains to a photoelectric conversion device comprising said electrode layer, a ...
03/17/2011
20110046182EFFICIENT ASPIRIN PRODRUGS
Aspirin is one of the most widely used drugs in the treatment of inflammation, pain and fever. It has more recently found application in the prevention of heart attacks and stroke and is being studied as a cancer chemopreventative agent. Despite its value aspirin contin...
02/24/2011
20110039821Fused Phenyl Amido Heterocyclic Compounds
The present invention relates to a compound of formula (I):

    • or a pharmaceutically accept...
02/17/2011
20110021540Bis-(Sulfonylamino) Derivatives in Therapy 066
The invention provides compounds of formula wherein R1, R3, L1, L2, G1, G2, A and m are as defined in the specification and optical isomers, racemates and tautomers thereof, and pharmaceutically acceptabl...
01/27/2011
20110015185Benzofuran Compounds
The present invention relates to compounds of formula (I):

wherein
P, R3, W1, and W2 are as described herein, to pharmaceutical compositions comprising the compounds, to...

01/20/2011
20100331370Novel isobenzofuran analogs of sclerophytin A
Isobenzofuran analogs of sclerophytin A are prepared in a highly concise fashion via an aldol-cycloaldol sequence. The analogs exhibit IC50's as low as 1 μM in growth inhibitory studies against KB3 cells using an MTT assay. Preferred analogs have one ...
12/30/2010
20100311582CHEMICAL COMPOUNDS
A compound of the formula (I) where, for example, W, X and Y are each CH; R1 and R6, independently of each other, are for example, selected from the group consisting of H, C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-alkoxy, C3-C8-cycloalkyl, R...
12/09/2010
20100292190NOVEL TUBULIN POLYMERISATION INHIBITORS
The present invention relates to compounds of general formula (I) as tublin polymerisation inhibitors and methods for preparing such compounds.

...

11/18/2010
20100267947EXO-SELECTIVE SYNTHESIS OF HIMBACINE ANALOGS
This application discloses a novel process for the synthesis of himbacine analogs, as well as the compounds produced thereby. The synthesis proceeds by alternative routes including the cyclic ketal amide route, the chiral carbamate amide route, and the chiral carbamate ...
10/21/2010
20100179137PYRIDONE COMPOUND
[Solving Means] The present inventors have conducted extensive studies on an EP4 receptor agonist, and as a result, found that a novel pyridone compound characterized in that the 1-position in the pyridone ring is substituted with a group having an acidic group such as ...
07/15/2010
20100137298Biaryl Sulfonamides and Methods for Using Same
The present invention relates to biaryl sulfonamides and their use as, for example, metalloproteinase inhibitors....
06/03/2010
20100125073BENZOFURAN AND BENZOTHIOPHENE DERIVATIVES USEFUL IN THE TREATMENT OF CANCERS OF THE CENTRAL NERVOUS SYSTEM
The present invention relates to benzofuran and benzothiophene derivatives and compositions containing such compounds for the production of medicaments for the treatment of cancers of the central nervous system as monotherapy or combination with other agents....
05/20/2010
20100123123ORGANIC THIN-FILM TRANSISTORS
A thin-film transistor comprises a semiconducting layer comprising a semiconducting material selected from Formula (I) or (II):

wherein X, R1, R2, R3, R4, R5 <...

05/20/2010
20100120760BENZOFURAN-CARBOXAMIDE DERIVATIVES AS ANTIVIRAL AGENTS
A compound of the formula (I): as defined herein, or a pharmaceutically acceptable salt thereof, or a pharmaceutical composition containing a compound of the formula (I) for use in inhibiting hepatitis C virus polymerase and/or of treating or preventing an illness due t...
05/13/2010
20100121062Slow Release of Organoboronic Acids in Cross-Coupling Reactions
A method of performing a chemical reaction includes reacting a compound selected from the group consisting of an organohalide and an organo-pseudohalide, and a protected organoboronic acid represented by formula (I) in a reaction mixture:

...

05/13/2010
20100093806PHOSPHODIESTERASE 4 INHIBITORS, INCLUDING AMINOINDAZOLE AND AMINOBENZOFURAN ANALOGS
PDE4 inhibition is achieved by novel compounds, e.g., aminoindazole and aminobenzofuran analogs. The compounds of the present invention are of Formulas I and II:

wherein R1, R2, R3<...

04/15/2010
20100081658HETEROCYCLIC ANTIVIRAL COMPOUNDS
Compounds having the formula I wherein R1, R2a, R2b, R2c, R3, Y and p are as defined herein and C2-C3 is a single or double bond are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and ...
04/01/2010
20100062937BENZANILIDES WITH INSECTICIDAL ACTIVITY
Benzanilides of the formula:

in which X represents hydrogen, halogen, nitro, C1-6 alkylthio, C1-6 alkylsulfinyl, C1-6 alkylsulfonyl or C1-6 alkylsulfonyloxy; Y repr...

03/11/2010
20100056796Compounds Suitable As Precursors to Compounds that are Useful for Imaging Amyloid Deposits
The present invention relates to novel derivatives that are suitable as precursors to compounds that are useful for imaging amyloid deposits in living patients, their compositions, methods of use and processes to make such compounds. The compounds deriving from these pr...
03/04/2010
20100004208SUBSTITUTED BENZOFURANS, BENZOTHIOPHENES, BENZOSELENOPHENES AND INDOLES AND THEIR USE AS TUBULIN POLYMERISATION INHIBITORS
The present invention relates generally to substituted benzofurans, benzothiophenes, and indoles and their use as tubulin polymerisation inhibitors....
01/07/2010
20090306055PHENYLAZOLE COMPOUNDS, PRODUCTION PROCESS AND ANTIOXIDANTS
The present invention is directed to compounds represented by the formula (1):

B-D-Z (1), wherein B represent the following formula (B-1),

A represents an optionally substituted ...

12/10/2009
20090306112ANTIVIRAL PROTEASE INHIBITORS
The invention is related to compounds of Formula I or a pharmaceutically acceptable salt, solvate, ester, and/or phosphonate thereof, compositions containing such compounds, and therapeutic methods that include the administration of such compounds.

12/10/2009
20090281138Bis-(Sulfonylamino) Derivatives in Therapy 066
The invention provides compounds of formula

wherein R1, R3, L1, L2, G1, G2, A and m are as defined in the specification and optical isomers, r...

11/12/2009
20090281321EXO- AND DIASTEREO- SELECTIVE SYNTHESES OF HIMBACINE ANALOGS
This application discloses a novel process for the preparation of himbacine analogs useful as thrombin receptor antagonists. The process is based in part on the use of a base-promoted dynamic epimerization of a chiral nitro center. The chemistry taught herein can be exe...
11/12/2009
1    
 
Sign InRegister
Username  
Password   
forgot password?